Gut Microbiota on the Incidence of Hypertension in Elderly Aged 60-89 Years : Scoping Review
DOI:
https://doi.org/10.35473/jgk.v18i1.879Keywords:
Gut, Microbiota, Hypertension, ElderlyAbstract
Hypertension is a growing global health problem. Identification of the causes of hypertension is highly variable and challenging, but in reality, it is multifactorial, both internal and external, including genetic, environmental, hormonal, and inflammatory factors. Hypertensive patients have decreased gut microbiota diversity, which is strongly correlated with the presence of gram-negative bacteria, such as Klebsiella, Streptococcus, Parabacteria, Desulfovibrio, Prevotella. This article aims to review the results of previous research related to the influence of gut microbiota on the incidence of hypertension in the elderly, as well as the mechanisms that link gut microbiota to the occurrence of hypertension in the elderly. The method used is a scoping review with the PICOS approach (Population, Intervention, Comparison, Outcome, Study Design) in compiling questions as a reference to identify keyword concepts that are appropriate to the objectives and questions reviewed and to determine inclusion and exclusion criteria. The elderly tend to have more Enterobacteriaceae and Oscillospira associated with inflammation, whereas younger people have more Bifidobacteria and SCFA-producing bacteria. The elderly with hypertension exhibit significant differences in gut microbiota composition. Longer-lived individuals have a higher proportion of short-chain fatty acid (SCFA)-producing bacteria such as Bacteroides, Faecalibacterium, and Alistipes, which play a role in stabilizing blood pressure through acetate production. The gut microbiota is a key component in the pathophysiology of hypertension in the elderly, with dysbiosis contributing to inflammation, metabolic disturbances, and decreased therapeutic efficacy. The reviewed studies suggest that SCFA-producing microbiota have protective effects and may be a potential target in hypertension management strategies.
Downloads
References
Avery, E. G., Bartolomaeus, H., Maifeld, A., Marko, L., Wiig, H., Wilck, N., Rosshart, S. P., Forslund, S. K., & Müller, D. N. (2021). The Gut Microbiome in Hypertension: Recent Advances and Future Perspectives. Circulation Research, 128(7), 934–950. https://doi.org/10.1161/CIRCRESAHA.121.318065
Haran, J. P., & McCormick, B. A. (2021). Aging, Frailty, and the Microbiome: How Dysbiosis Influences Human Aging and Disease. Gastroenterology, 160(2), 507–523. https://doi.org/10.1053/j.gastro.2020.09.060.Aging
Hung, H. C., Lin, Y. Y., Tien, W. J., Chen, Y. Y., & Yang, S. C. (2025). Association between the gut microbiotic composition and dietary patterns in hypertensive elderly patients: a cross-sectional study. Nutrition and Metabolism, 22(1). https://doi.org/10.1186/s12986-025-00963-8
Jiang, D., Chang, Y., Zhen, X., & Zhao, X. (2025). The causal effect of gut microbiome on pulmonary artery hypertension based on a two-sample Mendelian randomization study. Nutrition and Metabolism , 22(1). https://doi.org/10.1186/s12986-025-00979-0
Kaye, D. M., Shihata, W. A., Jama, H. A., Tsyganov, K., Ziemann, M., Kiriazis, H., Horlock, D., Vijay, A., Giam, B., Vinh, A., Johnson, C., Fiedler, A., Donner, D., Snelson, M., Coughlan, M. T., Phillips, S., Du, X. J., El-Osta, A., Drummond, G., … Marques, F. Z. (2020). Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease. Circulation, 141(17), 1393–1403. https://doi.org/10.1161/CIRCULATIONAHA.119.043081
Kementerian Kesehatan Republik Indonesia, B. K. P. K. (2023). Survei Kesehatan Indonesia (Vol. 01).
Levac, D., Colquhoun, H., & O’Brien, K. K. (2010). Scoping studies: Advancing the methodology. Implementation Science, 5(1), 1–9. https://doi.org/10.1186/1748-5908-5-69
Li, J., Zhao, F., Wang, Y., Chen, J., Tao, J., Tian, G., Wu, S., Liu, W., Cui, Q., Geng, B., Zhang, W., Weldon, R., Auguste, K., Yang, L., Liu, X., Chen, L., Yang, X., Zhu, B., & Cai, J. (2017). Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome, 5(1), 1–19. https://doi.org/10.1186/s40168-016-0222-x
Raymond, J. L., & Morrow, K. (2021). Krause and Mahan’s Food and Nutrition Care Process (15th ed.). Elsevier.
Silveira-Nunes, G., Durso, D. F., Jr, L. R. A. de O., Cunha, E. H. M., Maioli, T. U., Vieira, A. T., Speziali, E., Corrêa-Oliveira, R., Martins-Filho, O. A., Teixeira-Carvalho, A., Franceschi, C., Rampelli, S., Turroni, S., Brigidi, P., & Faria, A. M. C. (2020). Hypertension Is Associated With Intestinal Microbiota Dysbiosis and Inflammation in a Brazilian Population. Frontiers in Pharmacology, 11(March). https://doi.org/10.3389/fphar.2020.00258
Tukhovskaya, E. A., Ismailova, A. M., Perepechenova, N. A., Slashcheva, G. A., Palikov, V. A., Palikova, Y. A., Rzhevsky, D. I., Rykov, V. A., Novikova, N. I., Dyachenko, I. A., & Murashev, A. N. (2024). Development and Worsening of Hypertension with Age in Male Wistar Rats as a Physiological Model of Age-Related Hypertension: Correction of Hypertension with Taxifolin. International Journal of Molecular Sciences, 25(20). https://doi.org/10.3390/ijms252011216
Valdez-palomares, F., Texis, T., Sánchez-garcía, S., Martínez-ezquerro, J. D., Torre, P. G., Rodríguez-dorantes, M., Genis-mendoza, A., Fabela, S., Palacios-gonzález, B., & González-covarrubias, V. (2025). Changes in the gut microbiome of older adults according to hypertension control. Frontiers in Microbiology, 1–12. https://doi.org/10.3389/fmicb.2025.1605271
Verhaar, B. J. H., Collard, D., Prodan, A., Levels, J. H. M., Zwinderman, A. H., Backhed, F., Vogt, L., Peters, M. J. L., Muller, M., Nieuwdorp, M., & Van Den Born, B. J. H. (2020). Associations between gutmicrobiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: The HELIUS study. European Heart Journal, 41(44), 4259–4267. https://doi.org/10.1093/eurheartj/ehaa704
Yang, Z., Wang, Q., Liu, Y., Wang, L., Ge, Z., Li, Z., Feng, S., & Wu, C. (2023). Gut microbiota and hypertension: association, mechanisms and treatment. Clinical and Experimental Hypertension, 45(1). https://doi.org/10.1080/10641963.2023.2195135
Zhang, Q., Meng, N., Liu, Y., Zhao, H., Zhao, Z., Hao, D., Li, R., Han, K., Li, H., Ma, J., Yu, X., Qi, Z., & Li, Q. (2023). Protection effect of gut microbiota composition and acetate absorption against hypertension-induced damages on the longevity population in Guangxi, China. Frontiers in Nutrition, 9(January), 1–15. https://doi.org/10.3389/fnut.2022.1070223
